相关实验视频
Updated: Jan 11, 2026

06:27
Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
8.5K
与弗罗塞米德在早产婴儿中使用相关的中性症
Gillean K Connolly1, Jennifer Keates-Baleeiro1,2, Valerie Curren1,3
1Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Case reports in pediatrics
|November 19, 2025
概括
富罗塞米德是一种常见的利尿剂,可能会导致早产婴儿的中性贫血 (低白细胞数). 这项案例研究表明,罗塞米德是可能的原因,突出了罕见但严重的药物不良反应.
科学领域:
- 儿科药理学 儿科药理学
- 血液学 血液学 血液学
- 临床毒理学 临床毒理学
背景情况:
- 富罗塞米德是一种被广泛使用的循环利尿剂.
- 白血病,特别是中性病,是furosemide的一种不常见的副作用.
- 有限的临床数据存在于furosemide诱导的新生儿中性质减退.
研究的目的:
- 报告在接受furosemide的早产婴儿中发生的中性缺血病例.
- 用纳兰乔尺度评估罗西米德和中性衰竭之间的潜在因果关系.
- 讨论监测早产婴儿在利尿剂治疗中的影响.
主要方法:
- 一个早产婴儿患有先天性心脏异常的病例报告.
- 在两次住院期间,口服和静脉注射罗塞米德.
- 使用Naranjo尺度对药物不良反应概率的评估.
- 不同诊断包括感染,过敏和生理学点.
主要成果:
- 在furosemide治疗期间,婴儿出现了中性缺血症.
- 纳兰乔尺度表明,富罗塞米德和中性衰竭之间存在可能的因果关系.
- 感染,过敏和生理极点被认为是不太可能的原因.
结论:
- 罗西米德是可能导致这个早产婴儿中性缺血的原因.
- 建议对接受罗西米德的新生儿进行密切的血液学监测.
- 这一案例强调了认识到对常用药物的罕见不良药物反应的重要性.
相关概念视频
Renal Failure: Dose Adjustments
414
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
414
Pharmacokinetics in Pediatric Patients: Drug Excretion
196
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
196
Pharmacokinetics in Pediatric Patients: Drug Distribution
247
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
247
Nephrotic Syndrome I : Introduction
476
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
476
Drug Dosing: Infants and Children
235
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
235
Acute Kidney Injury IV: Diagnostic Studies and Prevention
249
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
249

